Springer, Clinical and Translational Oncology, 2(22), p. 223-235, 2020
DOI: 10.1007/s12094-019-02284-8
Full text: Download
AbstractThyroid carcinoma is the most frequent endocrine malignancy and accounts for around 3% of global cancer incidence. Different histologies and clinical scenarios make necessary a multidisciplinary approach that includes new diagnostic methods and surgical, radiopharmaceutical and systemic therapies. This guideline updates several aspects of management of thyroid cancer.